McKesson Other Current Assets 2010-2024 | MCK

McKesson other current assets from 2010 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • McKesson other current assets for the quarter ending June 30, 2024 were $M, a NAN% increase year-over-year.
  • McKesson other current assets for 2024 were $0B, a NAN% decline from 2023.
  • McKesson other current assets for 2023 were $0B, a 100% decline from 2022.
  • McKesson other current assets for 2022 were $4.516B, a 37533.33% increase from 2021.
McKesson Annual Other Current Assets
(Millions of US $)
2024 $
2023 $
2022 $4,516
2021 $12
2020 $906
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
McKesson Quarterly Other Current Assets
(Millions of US $)
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31 $14
2022-09-30 $2,825
2022-06-30 $3,155
2022-03-31 $4,516
2021-12-31 $5,534
2021-09-30 $3,086
2021-06-30 $7
2021-03-31 $12
2020-12-31 $15
2020-09-30 $833
2020-06-30 $844
2020-03-31 $906
2019-12-31 $856
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31 $2,002
2016-09-30 $1,767
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $65.897B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.818B 18.37
Cardinal Health (CAH) United States $26.800B 14.83
West Pharmaceutical Services (WST) United States $22.575B 44.02
Cooper (COO) United States $22.126B 31.50
Align Technology (ALGN) United States $19.210B 37.11
Labcorp (LH) United States $18.857B 15.71
Henry Schein (HSIC) United States $9.191B 16.83
Merit Medical Systems (MMSI) United States $5.834B 30.84
DENTSPLY SIRONA (XRAY) United States $5.453B 14.62
CONMED (CNMD) United States $2.323B 20.20
Patterson (PDCO) United States $1.962B 10.35
STAAR Surgical (STAA) United States $1.554B 70.22
Lifevantage (LFVN) United States $0.129B 17.76
Pro-Dex (PDEX) United States $0.093B 44.55